| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/11/2001 | WO2001002598A2 Screening for compounds modulating mitochondrial proton leak |
| 01/11/2001 | WO2001002594A2 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER |
| 01/11/2001 | WO2001002593A2 Control of gene expression in eukaryotic cells |
| 01/11/2001 | WO2001002592A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | WO2001002588A2 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 01/11/2001 | WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | WO2001002583A2 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 01/11/2001 | WO2001002578A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002568A2 Human genes and gene expression products |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002565A2 Secreted protein zacrp4 |
| 01/11/2001 | WO2001002563A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/11/2001 | WO2001002561A2 Mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | WO2001002557A1 Neurotrophic factor receptor |
| 01/11/2001 | WO2001002553A2 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression |
| 01/11/2001 | WO2001002552A2 Double transgenic animals as models for neurodegenerative disease |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002550A2 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | WO2001002549A2 Homomeric and heteromeric ampa receptors |
| 01/11/2001 | WO2001002540A2 Adenoviral vectors for treating disease |
| 01/11/2001 | WO2001002539A1 Microchamber for embryo cell culture |
| 01/11/2001 | WO2001002460A1 Biodegradable block copolymers with modifiable surface |
| 01/11/2001 | WO2001002440A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | WO2001002436A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | WO2001002430A2 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 01/11/2001 | WO2001002420A1 PURIFIED AND ISOLATED MAT II β SUBUNIT NUCLEIC ACIDS AND POLYPEPTIDES AND THERAPEUTIC AND SCREENING METHODS USING SAME |
| 01/11/2001 | WO2001002030A2 Scaffold matrix and tissue maintaining systems |
| 01/11/2001 | WO2001002019A2 Control of gene expression |
| 01/11/2001 | WO2001002005A2 Treatment of dentritic cells for induction of immune tolerance |
| 01/11/2001 | WO2001001867A1 Personal cervical cell collector |
| 01/11/2001 | WO2001001767A1 Hydrocephaly model animals |
| 01/11/2001 | WO2001001762A1 Construction of rice tolerant to iron deficiency |
| 01/11/2001 | WO2001001761A1 Method of regenerating individual of plant belonging to the genus lilium |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000059515A3 Immunomodulating polymers |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000056375A3 Mineralization and cellular patterning on biomaterial surfaces |
| 01/11/2001 | WO2000055302A3 Genetically modified plants having modulated brassinosteroid signaling |
| 01/11/2001 | WO2000053748A3 Casb618 polynucleotides and polypeptides and their use |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000046251A3 Human polyclonal antibodies from transgenic nonhuman animals |
| 01/11/2001 | WO2000039278A8 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 01/11/2001 | WO2000029561A8 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/11/2001 | WO2000029551B1 Cells, culture methods, and their use in autologous transplantation therapy |
| 01/11/2001 | WO2000029012A8 Methods of alleviating cancer symptoms |
| 01/11/2001 | DE19931883A1 DNA kodierend für Beta-Tubulin und deren Verwendung DNA coding for beta-tubulin, and the use thereof |
| 01/11/2001 | DE19930729A1 Blockcopolymere zur Herstellung biomimetischer Oberflächen Block copolymers for the preparation of biomimetic surfaces |
| 01/11/2001 | DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the |
| 01/11/2001 | CA2750854A1 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2378951A1 Secreted protein zacrp4 |
| 01/11/2001 | CA2378539A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | CA2378477A1 Induction of immune tolerance |
| 01/11/2001 | CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377932A1 Control of gene expression in eukaryotic cells |
| 01/11/2001 | CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | CA2377929A1 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression |
| 01/11/2001 | CA2377804A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | CA2377768A1 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | CA2377731A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | CA2377684A1 Screening method |
| 01/11/2001 | CA2377378A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phosphotransferase system proteins |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2376166A1 Control of gene expression |
| 01/11/2001 | CA2374386A1 Plant proteins |
| 01/11/2001 | CA2373352A1 Adenoviral vectors for treating disease |
| 01/11/2001 | CA2372935A1 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | CA2372742A1 Double transgenic animals as models for neurodegenerative disease |
| 01/10/2001 | EP1067189A1 Gene encoding flavone synthase |
| 01/10/2001 | EP1067188A1 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR) |
| 01/10/2001 | EP1067141A1 A male-specific protein homologue involved in histocompatibility |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | EP1066396A1 Nucleic acid transfer vectors, compositions containing same and uses |
| 01/10/2001 | EP1066395A1 Inducible alphaviral gene expression system |
| 01/10/2001 | EP1066394A2 Novel basal endosperm transfer cell layer (betl) specific genes |
| 01/10/2001 | EP1066392A1 Vectors for gene mutagenesis and gene discovery |
| 01/10/2001 | EP1066389A2 Isochorismate synthase and its use for the induction of resistance in plants |
| 01/10/2001 | EP1066381A1 Human vanilloid receptor homologues |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066373A1 Phytase variants |
| 01/10/2001 | EP1066370A1 Stimulated monocyte derived cells, their preparation and uses |
| 01/10/2001 | EP1066369A1 Selection subtraction approach to gene identification |
| 01/10/2001 | EP1066328A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 01/10/2001 | EP1066325A1 G-protein fusion receptors and chimeric gaba b? receptors |
| 01/10/2001 | EP1066324A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 01/10/2001 | EP1066320A1 Orphan nuclear receptor |
| 01/10/2001 | EP1066311A1 Compositions and methods for the identification of lung tumor cells |
| 01/10/2001 | EP1066310A1 Neokine protein and nucleic acid molecules and uses therefor |
| 01/10/2001 | EP1066060A2 Mesenchymal stem cells as immunosuppressants |
| 01/10/2001 | EP1066052A2 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 01/10/2001 | EP1066051A1 Sciellin and uses thereof |
| 01/10/2001 | EP1066050A2 Application of hsp70 proteins |
| 01/10/2001 | EP1066028A2 Methods and devices for modulating the immune response |
| 01/10/2001 | EP0730643B1 Transgenic animals harboring app allele having swedish mutation |
| 01/10/2001 | CN1279723A Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 01/10/2001 | CN1279721A Multiply-substituted protease variants |